Immunization of patients with bleeding disorders

Haemophilia

Volumn 9, Issue 5, 2003, Pages 541-546

  Makris, M ^a   Conlon, C P ^b   Watson, H G ^c  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Bleeding disorder; Haemophilia; Immunization; Vaccination

Indexed keywords

ANTHRAX VACCINE; BCG VACCINE; CHOLERA VACCINE; DIPHTHERIA VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HERPES VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; ORAL POLIOMYELITIS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; RUBELLA VACCINE; TETANUS TOXOID; TICK BORNE ENCEPHALITIS VACCINE; TYPHOID VACCINE; YELLOW FEVER VACCINE;

ADOLESCENT; AGE; BLEEDING DISORDER; BLOOD TRANSFUSION; CHILD; CHILD CARE; DIPHTHERIA; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; FEMALE; HEMATOMA; HEMOPHILIA; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; INFANT; INFLUENZA; INJECTION SITE; MALE; MEASLES; MENINGOCOCCOSIS; MUMPS; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; RABIES; REVIEW; RISK ASSESSMENT; RUBELLA; TRAVEL; TUBERCULOSIS; TYPHOID FEVER; YELLOW FEVER;

EID: 0141955859     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2003.00819.x     Document Type: Review

References (15)

1. Evans DIK, Shaw A. Safety of intramuscular injection of hepatitis B vaccine in haemophiliacs. BMJ 1990; 300: 1694-5.
2. Zuckerman J. The importance of injecting vaccines into muscle. BMJ 2000; 321: 1237-8.
3. Richardson LC, Evatt BL. Risk of hepatitis A virus infection in persons with haemophilia receiving plasma derived products. Transfus Med Rev 2000; 14: 64-73.
4. Vento S, Garofano T, Renzini C et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998; 338: 286-90.
5. Stanley SK, Ostrowski MA, Justement JS et al. Effect of immunisation with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996; 334: 1222-30.
6. American Academy of Pediatrics. Measles. In: Peter GRed Book. Report of the Committee on Infectious Diseases, 24th edn. Elk Grove Village, IL: American Academy of Pediatrics, 1997: 348-50.
7. Centre for Disease Control and Prevention. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993. MMWR, Morbidity and Mortality Weekly Report 1996; 45: 603-6.
8. American Academy of Pediatrics. Measles immunization in HIV-infected children. American Society of Pediatrics, Committee on Infectious Diseases and Committee on Pediatric AIDS. Pediatrics 1999; 103: 1057-60.
9. Fuller JD, Craven DE, Steger KA, et al. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis 1999; 28: 541-7.
10. Macias J, Pineda JA, Leal M et al. HIV-1 plasma viraemia is not increased in patients receiving highly active antiretroviral therapy after influenza vaccination. Eur J Clin Microbiol Infect Dis 2001; 20: 46-8.
11. Sullivan PS, Hanson DL, Dworkin MS, Jones JL, Ward JW. Adult and adolescent spectrum of HIV disease investigators. Effect of influenza vaccination on disease progression among HIV infected persons. AIDS 2000; 14: 2781-5.
12. Breiman RF, Keller DW, Phelan MA et al. Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for the HIV-infected patients. Arch Intern Med 2000; 160: 2633-8.
13. French N, Nakiyingi J, Carpenter LM et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000; 355: 2106-11.
14. NHS Travel Advice. Website:http://www.doh.gov.uk/traveladvice/tables.htm.
15. Scottish NHS Travel Advice Website:http://www.fitfortravel.scot.nhs.uk.